Sanuwave Health Inc.

SNWV Healthcare Medical Devices

Sanuwave Health Inc.’s revenue for fiscal 2025 (year ended December 2025) was $44.1 million, up 35.0% from fiscal 2024. In the quarter to June 2026, revenue fell 3.13%, EPS fell 224.2%, free cash flow grew 86.8% and total debt fell 28.4%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three.

4.96 0.21 −4.06%
Market cap
$44.5M
P/E
3.0×
Fwd P/E
−211×
Dividend yield
—
F-score
6/9
Altman Z
−2.97
Beneish M
−0.90
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Piotroski F-Score
3 4 3 4 4 3 5 4 5 6
P/E ratio
2.49 2.49 2.49 2.49 2.49 2.49 2.49 2.49 0.00 22.70
P/S ratio
1.42 1.42 1.42 1.42 1.42 1.42 1.42 1.42 3.15 5.80
Altman Z-Score
— — — — — — — — (10.06) (2.97)
P/FCF ratio
117.92 117.92 117.92 117.92 117.92 117.92 117.92 117.92 52.24 34.96
Altman Z″-Score (non-manufacturers)
(391.38) (339.69) (450.52) (158.70) (37.98) (56.29) (53.29) (48.94) (32.94) (19.06)
P/Operating CF
32.38 32.38 32.38 32.38 32.38 32.38 32.38 32.38 138.52 76.99
Beneish M-Score
(14.22) (18.29) (33.36) (2.12) 3.54 (6.45) (0.43) (6.97) (7.78) (0.90)
P/B ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 157.84
EV/Sales
2.17 2.17 2.17 2.17 2.17 2.17 2.17 2.17 3.61 6.03
EV/EBITDA
5.74 5.74 5.74 5.74 5.74 5.74 5.74 5.74 11.20 34.53
EV/FCF
180.56 180.56 180.56 180.56 180.56 180.56 180.56 180.56 59.94 36.33
Current Ratio
0.12 0.11 0.07 0.20 0.22 0.08 0.11 0.15 0.41 1.38
Net Debt/EBITDA
0.03 (0.03) (1.19) 0.11 (0.09) (1.24) (4.35) 2.85 1.44 1.30
Debt/Equity
(0.01) (0.08) (0.35) (0.08) (0.33) (0.32) (0.35) (0.53) (1.61) 13.56
ROE
100.69% 65.96% 92.18% 82.06% 260.18% 103.50% 25.74% 61.31% 112.20% (166.66%)
ROA
(655.94%) (484.99%) (946.99%) (457.48%) (234.29%) (130.91%) (53.48%) (122.05%) (125.95%) 35.02%
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 26.60%
Return on Tangible Assets
92.98% 55.97% 75.89% 106.24% 111.38% 53.61% 19.52% 47.76% 123.80% 134.97%
Average Days of Receivables
122.22 75.37 46.32 26.79 211.96 67.75 87.84 59.30 37.23 44.93
Earnings Yield
40.22% 40.22% 40.22% 40.22% 40.22% 40.22% 40.22% 40.22% (30.35%) 4.40%
Free Cash Flow Yield
0.85% 0.85% 0.85% 0.85% 0.85% 0.85% 0.85% 0.85% 1.91% 2.86%
Free Cash Flow per Share
(11.04) (4.08) (9.07) (11.76) (12.51) (4.96) (11.35) (2.13) 0.44 0.85
Book value per Share
(23.78) (26.36) (38.03) (18.31) (13.44) (27.84) (27.64) (20.40) (3.54) 0.19
Free Cash Flow
(3.21) (1.53) (3.66) (6.46) (12.77) (6.94) (16.84) (4.52) 1.97 7.31
EV/EBIT
16.16 16.16 16.16 16.16 16.16 16.16 16.16 16.16 30.61 53.70
Other line items

Show all line items

Columns are period end dates